Claire has worked in the development of scientific networks and associations for over 20 years. Following a degree in agriculture and a PhD in crop science, she worked in scientific communications and as a biotechnology National Contact Point for Framework Programme Five. Her work took her to the fast growing Cambridge (UK) biotechnology cluster in 2000, where she was part of her first business association (now One Nucleus) from where, as part of a Europe-wide founding team, she launched the Council of European BioRegions (CEBR), a network of biotechnology clusters. Her role as Network Manager for CEBR brought her to Brussels in 2009, where she also became Secretary General of the European Biotechnology Network, a network with the mission to build collaboration for exploitation of science. Through EBN she became involved in the Innovatove Medicines Initiative (IMI) within the ENABLE project, which developed novel Gram negative antibacterial candidates. In 2016, Claire took on a global role as Director General of the Nanotechnology Industries Association (NIA), representing nanomaterials across sectors, with focus on the emerging regulatory frameworks worldwide and the positioning of nanomaterials in advanced products and processes. In 2020, she joined EuropaBio as Director General, representing biotechnology across sectors and helping to shape the role that it plays in Europe’s delivery of a sustainable and healthy future.